William McCombe serves as the Chief Financial Officer (CFO) at Cytek Biosciences Inc., a leading provider of cell analysis solutions. With a robust background in finance and strategic planning, McCombe has been instrumental in steering the company's financial strategies and growth initiatives. He joined Cytek Biosciences in 2021, bringing with him a wealth of experience from his previous roles in the life sciences and technology sectors. Prior to his tenure at Cytek Biosciences, McCombe held significant positions at several high-profile companies. He was the CFO at Fluidigm Corporation, where he played a key role in driving financial performance and operational efficiency. Before Fluidigm, he served as the CFO at Pacific Biosciences, where he was pivotal in navigating the company through its growth phase and IPO. McCombe's career also includes a stint at Affymetrix, where he honed his skills in financial management and strategic planning. His extensive experience in the life sciences industry has equipped him with the insights necessary to lead Cytek Biosciences through its expansion and innovation efforts. As CFO at Cytek Biosciences, McCombe is responsible for overseeing the company's financial operations, including budgeting, forecasting, and investor relations. Under his leadership, Cytek has successfully expanded its product offerings and market presence, solidifying its position as a leader in the cell analysis market. McCombe's strategic vision and financial acumen have been crucial in supporting the company's mission to advance scientific discovery and improve patient outcomes. His contributions have not only enhanced the company's financial health but also reinforced its commitment to innovation and excellence in the life sciences sector.